Table 4.

Reasons for discontinuation during 1–5 courses of treatment (6 months)

Reason for discontinuation	Control group		Study group
	n = 138	%	n = 124	%
Severe AEs
Hematologic toxicity	2	1.4	6	4.8
Nonhematologic toxicity	30	21.7	20	16.1
Complication	5	3.6	4	3.2
Patient refusal
Reasons other than AEs	14	10.1	23	18.5
Because of AEs	30	21.7	11	8.9
Over rest period	32	23.2	37	29.8
Others	25	18.1	23	18.5